Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Veea boosts leadership team to speed up growth and market expansion of its AI-native edge platform.

Market News
22 Jun 2026
Na
View Source
Bullish
pluang ai news

Veea Inc. has promoted Greg Deisher to COO, elevated Mark Tubinis to Executive VP, and appointed Thomas Latiolais as CMO to strengthen its leadership amid rapid growth. These moves aim to accelerate commercial growth and expand Veea's AI-powered edge infrastructure platform into new enterprise and industrial markets globally. The leadership changes enhance operational execution, commercial strategy, and marketing to support scaling and adoption of Veea's AI-native hyperconverged networking solutions. This signals Veea's commitment to meeting growing demand for secure, intelligent edge computing worldwide.

More News

GXO opens new sustainable distribution center in Ferentino to support Action's growth in Italy

GXO opens new sustainable distribution center in Ferentino to support Action's growth in Italy

GXO Logistics has launched a new distribution center in Ferentino, Italy, to support Action's expansion in Central and Southern Italy. The facility, GXO's second for Action in Italy, will grow its workforce from over 200 to 300 employees and features...

Market News
Bullish
1 hour ago
CureWise launches AI-driven platform to personalize cancer treatment and empower patients.

CureWise launches AI-driven platform to personalize cancer treatment and empower patients.

CureWise, led by founder Steve Brown, has launched an AI-powered precision oncology platform designed to help cancer patients understand their unique disease and explore personalized treatment options. The platform integrates medical records securely...

Others
Neutral
1 hour ago
Sitryx completes enrollment in Phase 1b trial of oral SYX-5219 for atopic dermatitis, data expected Q4 2026

Sitryx completes enrollment in Phase 1b trial of oral SYX-5219 for atopic dermatitis, data expected Q4 2026

Sitryx Therapeutics has completed enrollment ahead of schedule in its Phase 1b trial of SYX-5219, a first-in-class oral PKM2 modulator, targeting moderate to severe atopic dermatitis. The randomized, placebo-controlled study involves 50 adults across...

Company Fundamentals
Bullish
1 hour ago
Brunswick's Navico updates Lowell facility to cut costs, boost efficiency, and support US manufacturing.

Brunswick's Navico updates Lowell facility to cut costs, boost efficiency, and support US manufacturing.

Brunswick Corporation's Navico Group announced operational changes at its Lowell, Michigan facility aimed at reducing fixed costs and improving efficiency. The update includes expanding insourcing, collaborating with outside partners, and better spac...

Market News
Bullish
1 hour ago
WeRide, Geely Farizon, and Kwoon Chung launch right-hand-drive Robotaxis in Hong Kong, expanding autonomous mobility globally.

WeRide, Geely Farizon, and Kwoon Chung launch right-hand-drive Robotaxis in Hong Kong, expanding autonomous mobility globally.

WeRide, Geely Farizon, and Kwoon Chung Bus Holdings have jointly developed right-hand-drive Robotaxis tailored for markets like Hong Kong, where such vehicles are currently unavailable. This collaboration leverages each company's strengths in autonom...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App